Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes
NACompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
November 30, 2011
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE
Accu-Chek DiaPort
Trial Locations (1)
83670
Bad Heilbrunn
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT01483352 - Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes | Biotech Hunter | Biotech Hunter